Gynecologic Cancers Archives

A patient with cancer takes opioids for pain control.

Model Developed to Predict Postoperative Opioid Use After Gynecologic Surgery

By

Vicki Moore, PhD

August 4, 2022

Researchers developed a predictive tool and an online calculator to potentially mitigate excessive postoperative opioid use in women undergoing gynecologic procedures.

Ovarian Cancer

Cure Rate After Chemotherapy in Stage III Ovarian Cancer

By

Vicki Moore, PhD

August 3, 2022

Researchers found that 18% of patients with advanced ovarian cancer remained disease-free for at least 10 years after receiving chemotherapy and were likely cured.

Navigation

Health Outcomes Following In Utero Exposure to Maternal Cancer

By

Vicki Moore, PhD

August 2, 2022

Researchers in Denmark sought to determine whether in utero exposure to maternal cancer increased risks of overall mortality, somatic diagnoses, and psychiatric diagnoses.

Among female patients with CML, fertility preservation with ovarian stimulation can be challenging i

Gynecologic Cancer

Fertility Concerns a Significant Issue for Gynecologic Cancer Survivors

By

Jessica Nye, PhD

July 29, 2022

A systematic review sought to identify the survivorship issues important to survivors of gynecologic cancers.

It is unclear whether breast cancer screening — and specifically mammography — reduces the likelihoo

Cervical Cancer

Cervical Cancer Screening Interval Extensions Feasible With HPV Testing

By

Jennifer Larson

July 19, 2022

Researchers analyzed data from more than 1 million women to determine if screening intervals could be safely extended with negative human papillomavirus tests compared with negative cytology screen results.

Ovarian Cancer

Eligibility for First-Line PARP Inhibitor Maintenance in Advanced Ovarian Cancer

By

Lauren Dembeck, PhD

July 12, 2022

Many patients with advanced ovarian cancer may be eligible for first-line maintenance with a PARP inhibitor, research suggests.

Ovarian Cancer

Effect of HIPEC With Cytoreductive Surgery on HRQOL in Patients With Advanced Ovarian Cancer

By

Jessica Nye, PhD

July 11, 2022

A randomized study sought to determine the effect of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy on HRQOL for patients with advanced ovarian cancer.